Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal CarcinomaYuan Zhang, Jun Ma, Ling‐Long Tang et al.|New England Journal of Medicine|2019Cited by 934
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu‐Pei Chen, Jun Ma, Xu Liu et al.|The Lancet|2021Cited by 234
Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinomaFangzhu Wan, Xiaodong Zhu|Journal of Translational Medicine|2020Cited by 117
PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cellsZe-Tan Chen, Xiaodong Zhu|Molecular Medicine Reports|2015Cited by 43
Silencing of <em>c-jun</em> decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2RGuoxiang Lin, Xiaodong Zhu|OncoTargets and Therapy|2018Cited by 35